Routine adult
Adult pneumococcal immunisation (conjugate and/or polysaccharide, per current schedule). Strongly recommended for adults 65+ and younger adults with chronic disease.
Who should get it
- Adults 65 years and older
- Adults 19–64 with diabetes, heart, lung, liver, or kidney disease, HIV, or asplenia
- People who smoke or have alcohol-use disorder (risk-based)
Who should wait
- Moderate/severe acute illness — defer
Contraindications
- Anaphylaxis to a previous pneumococcal vaccine or a diphtheria-toxoid-containing vaccine (for PCV)
Precautions
- PPSV23 is less immunogenic if given too soon after PCV — pharmacist follows interval rules
Common side effects
- Sore arm
- Redness
- Mild fever
- Muscle aches
Rare risks
- Anaphylaxis
Indications
Prevention of invasive pneumococcal disease in older adults and at-risk younger adults.
Regulatory note
Product (PCV13/15/20 vs PPSV23) is selected at the point of care and recorded on the certificate.
